Skip to Content

WPI 3635 (Levetiracetam Extended Release 500 mg)

Pill with imprint WPI 3635 is White, Round and has been identified as Levetiracetam Extended Release 500 mg. It is supplied by Watson Laboratories, Inc..

Levetiracetam is used in the treatment of seizures; epilepsy; neuralgia; bipolar disorder; hyperekplexia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3635

Levetiracetam extended release 500 mg WPI 3635

Levetiracetam Extended Release

Imprint:
WPI 3635
Strength:
500 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3635

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide